Quote For Regen Therapeutics PLC RGNT.L
Regen Therapeutics PLC (RGNT.L) (London Stock Exchange)
sector: Healthcare ·
industry: Biotechnology ·
3.31p
8:47am GMT
+5.75%
3.13p
3.13p
22,250
3.34p
3.13p
8.25p
2.50p
0.97
96,003
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Lomax, Percy | Executive Chairman of the Board, Chief Executive Officer | 99,460 |
| Lott, Norman | Finance Director, Company Secretary, Director | 75,439 |
| Kruzel, Marian | Chief Scientific Officer | -- |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | £1.15 |
| Shares Outstanding (Mil.) | 36.73 |
| Float (Mil.) | 34.20 |
| Dividend Information | |
|---|---|
| Yield % | -- |
| Annual Dividend (£ GBP) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 0.36 |
| Current Ratio | 0.41 |
| LT Debt/Equity | 0.00 |
| Total Debt/Equity | 3.88 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 12.48 |
| Price/Book(TTM) | 0.35 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | £-0.12 |
| Sales(TTM) | £0.01 |
| Book Value(MRQ) | £0.09 |
| Cash Flow(TTM) | £-0.10 |
| Cash(MRQ) | £0.00 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -75.56 |
| Return on Assets(TTM) | -58.45 |
| Return on Investment(TTM) | -71.76 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 78.26 |
| Operating Margin(TTM) % | -1,647.83 |
| Profit Margin(TTM) % | -1,552.17 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
